Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin
Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia
- Li, Jing Jing, Tay, Hock L., Mattes, Joerg, Foster, Paul S., Yang, Ming, Maltby, Steven, Xiang, Yang, Eyers, Fiona, Hatchwell, Luke, Zhou, Hong, Toop, Hamish D., Morris, Jonathan C., Nair, Parameswaran
- Collison, Adam, Hatchwell, Luke, Verrills, Nicole, Wark, Peter A. B., Pereira De Siqueira, Ana, Tooze, Melinda, Carpenter, Helen, Don, Anthony S., Morris, Jonathan C., Zimmermann, Nives, Bartlett, Nathan W., Rothenberg, Marc E., Johnston, Sebastian L., Foster, Paul S., Mattes, Joerg
The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells
- Rahman, Md. Mostafizur, Prũnte, Laura, Lebender, Leonard F., Patel, Brijeshkumar S., Gelissen, Ingrid, Hansbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.
Are you sure you would like to clear your session, including search history and login status?